Mortality in Parkinson's disease and its association with dementia and depression

Acta Neurologica Scandinavica
T A HughesE G S Spokes

Abstract

To compare the mortality rate in Parkinson's disease (PD) with a control group without PD, and to assess the relationship between mortality and features of PD. Ninety PD patients and 50 controls, mortality ascertained at 11 years follow-up. The hazard ratio (HR) for mortality in PD patients compared with controls was 1.64 (95% CI: 1.21-2.23). Multivariate analysis showed age, dementia and depression were independent predictors of mortality but age at onset of PD and severity of neurological symptoms were not. The HR for age was 1.09 (95% CI: 1.05-1.13), for dementia 1.94 (95% CI: 1.26-2.99), and for depression 2.66 (95% CI: 1.59-4.44). Mortality in PD is increased compared with controls. Psychological variables are important predictors of mortality in PD.

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Feb 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R P SnaithP McGuffin
Jun 1, 1978·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·H E Nelson, A O'Connell
Jun 1, 1992·Acta Psychiatrica Scandinavica·T J HeerenH G Rooymans
Dec 1, 1991·Statistics in Medicine·D G Altman
Aug 15, 1991·American Journal of Epidemiology·D A EvansL E Hebert
Jan 1, 1990·The Journal of Nervous and Mental Disease·S E StarksteinR G Robinson
Feb 1, 1990·Psychological Medicine·R G Brown, B MacCarthy
Apr 1, 1990·Acta Neurologica Scandinavica·K P EbmeierW J Mutch
Jul 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·S E StarksteinR G Robinson
Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·W R Gibb, A J Lees
May 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·R P SnaithC Teale
Nov 14, 1985·The New England Journal of Medicine·T KircherH Burdo
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Mar 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·Y Ben-Shlomo, M G Marmot
Jan 11, 1996·The New England Journal of Medicine·D A BennettD A Evans
Feb 1, 1996·Archives of Neurology·E TandbergJ L Cummings
Mar 1, 1997·Archives of Neurology·E D LouisR Mayeux
Mar 26, 1999·BMJ : British Medical Journal·T G Dinan
Aug 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·M A HelyP M Williamson
Apr 18, 2000·Archives of Neurology·L MorganteG Savettieri
Aug 1, 1961·The Journal of Nervous and Mental Disease·G J CANTERM MIER

❮ Previous
Next ❯

Citations

Jan 4, 2012·Archives of Neurology·Allison W WillisBrad A Racette
Nov 10, 2006·Der Nervenarzt·S WenzelC Trenkwalder
Feb 15, 2008·Acta Neuropathologica·Kurt A Jellinger, Johannes Attems
Feb 28, 2008·Journal of Neural Transmission·K A Jellinger, J Attems
Nov 6, 2013·Current Neurology and Neuroscience Reports·Laura Marsh
Apr 2, 2011·Age and Ageing·Aaron Ratnaker Phillips, Richard William Genever
Dec 22, 2012·International Journal of Epidemiology·Meike KastenChristine Klein
Apr 28, 2006·Current Opinion in Psychiatry·Uwe Ehrt, Dag Aarsland
Aug 22, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E D LouisUNKNOWN Neurological Disorders in Central Spain (NEDICES) Study Group
Sep 18, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A Antonini
Sep 30, 2008·International Journal of Clinical Practice·W PoeweB Dubois
Jun 20, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Caroline H Williams-GrayRoger A Barker
Apr 3, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·Lianna S IshiharaAnette Schrag
Mar 29, 2007·Dementia and Geriatric Cognitive Disorders·Inga LiepeltDaniela Berg
Apr 15, 2010·Neuroepidemiology·Kyle SteenlandAllan Levey
May 10, 2011·Neuropsychiatric Disease and Treatment·Fernando Mv DiasAntônio Lúcio Teixeira
Sep 1, 2006·Neuropsychiatric Disease and Treatment·R Scott MackinAlexandra Elite-Marcandonatou
Sep 16, 2010·CNS Drugs·Angelo AntoniniGiovanni Abbruzzese
Nov 30, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Barbara Connolly, Susan H Fox
Mar 13, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Alberto CostaGiovanni Augusto Carlesimo
May 11, 2007·Acta Neurologica Scandinavica·Amos D Korczyn
Feb 2, 2013·Acta Neurologica Scandinavica·A A OjagbemiO Baiyewu
Sep 5, 2015·Journal of Neurology·Davide L VetranoGiuseppe Zuccalà
Jul 15, 2015·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Gang WangSheng-Di Chen
Sep 4, 2014·The American Journal of Chinese Medicine·Yi ZhangNai-Hong Chen
Nov 14, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Eva Pirogovsky-TurkDawn M Schiehser
Mar 7, 2012·Medical Hypotheses·Dennis J McCarthyGerard Sanacora
Nov 12, 2016·Journal of Advanced Pharmaceutical Technology & Research·K G PrakashArchana Rajagopalan
Mar 9, 2017·Bulletin of the Menninger Clinic·Muhammad Adnan KhanHassaan Tohid
Jun 27, 2006·Journal of the Neurological Sciences·K A Jellinger
Apr 1, 2014·Parkinsonism & Related Disorders·Lonneke M L de LauJacobus J van Hilten
Feb 22, 2013·Journal of Psychopharmacology·Fábio L RochaCíntia Fuzikawa
Aug 24, 2013·Journal of Geriatric Psychiatry and Neurology·Matej SkorvanekJitse P Dijk
May 11, 2012·American Journal of Alzheimer's Disease and Other Dementias·Rita MorettiGiuseppe Bellini
Dec 29, 2012·American Journal of Alzheimer's Disease and Other Dementias·Bingmei DengJun Wang
Sep 30, 2017·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Julie A Fields
Dec 2, 2017·Journal of Geriatric Psychiatry and Neurology·D Santos-GarcíaD Núñez-Arias
Jul 11, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Jennifer G GoldmanChristopher G Goetz
Jul 31, 2018·The European Journal of Neuroscience·Julia C GreenlandRoger A Barker
May 12, 2018·International Psychogeriatrics·Caitlin SwalwellNadeeka N Dissanayaka
Jun 10, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Kenichi SatoUNKNOWN Juntendo Parkinson Study Group
Nov 30, 2006·International Journal of Geriatric Psychiatry·Peijun ChenAlan M Mellow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Per-Arne FallAnn-Kathrine Granérus
Journal of Neurology, Neurosurgery, and Psychiatry
Mariese A HelyP M Williamson
Archives of Neurology
E D LouisR Mayeux
Movement Disorders : Official Journal of the Movement Disorder Society
A SchragChristopher Goetz
© 2022 Meta ULC. All rights reserved